Nanoparticle compositions comprising pancreatic enzymes
A nanoparticle composition with immobilized enzymes and protective polymer layer addresses EPI by maintaining enzymatic activity and stability, enhancing treatment efficacy for EPI.
WO2026132349A1PCT designated stage Publication Date: 2026-06-25PERSEO PHARMA AG
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- PERSEO PHARMA AG
- Filing Date
- 2025-12-18
- Publication Date
- 2026-06-25
Smart Images

Figure 00000065_0000 
Figure 00000066_0000 
Figure 00000066_0001
Abstract
The present invention relates to a composition comprising a solid carrier, a lipase or a fragment thereof immobilized on the surface of the solid carrier wherein the lipase or a fragment thereof is in the open conformation, a protease or a fragment thereof immobilized on the surface of the solid carrier, an amylase or a fragment thereof immobilized on the surface of the solid carrier, an agent which interacts with the lid domain of the lipase or a fragment thereof, a protective layer to protect the lipase or a fragment thereof, the protease or a fragment thereof and the amylase or a fragment thereof by embedding the lipase or a fragment thereof, the protease or a fragment thereof and the amylase or a fragment thereof, and a functional constituent immobilized on the surface of the protective layer, wherein the functional constituent immobilized on the surface of the protective layer is a polymer comprising repeat units wherein each repeat unit comprises at least one amino group and / or at least one thiol group; b) an amino acid; c) a non-reducing sugar and / or a non-reducing sugar alcohol; and d) a surfactant. The present invention also relates to solid, lyophilized and liquid compositions of said nanoparticle composition, capsules comprising said nanoparticle composition, methods of producing said nanoparticle composition and uses thereof.
Need to check novelty before this filing date? Find Prior Art